Page last updated: 2024-11-03

propantheline and Syndrome

propantheline has been researched along with Syndrome in 3 studies

Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.

Syndrome: A characteristic symptom complex.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schott, GD1
Loh, L1
Burbige, EJ1
Manning, RJ1
Belber, JP1
Cameron, JL1
Gayler, BW1
Hendrix, TR1

Other Studies

3 other studies available for propantheline and Syndrome

ArticleYear
Anticholinesterase drugs in the treatment of chronic pain.
    Pain, 1984, Volume: 20, Issue:2

    Topics: Arm; Cholinesterase Inhibitors; Chronic Disease; Humans; Leg; Male; Middle Aged; Neostigmine; Pain;

1984
Watery diarrhea syndrome with elevated levels of vasoactive intestinal polypeptide associated with pancreatitis and pancreatic pseudocyst.
    The American journal of gastroenterology, 1978, Volume: 70, Issue:2

    Topics: Adult; Diarrhea; Gastrointestinal Hormones; Humans; Male; Pancreatic Cyst; Pancreatitis; Propantheli

1978
The use of intramuscular propantheline in the short bowel syndrome.
    The Johns Hopkins medical journal, 1976, Volume: 138, Issue:3

    Topics: Adult; Female; Humans; Intestinal Diseases; Intestines; Postoperative Complications; Propantheline;

1976